Spontaneous resolution of vitreomacular traction following ranibizumab (Lucentis) injection.

PURPOSE

Spontaneous resolution of vitreomacular traction syndrome in diabetic patients is a rare phenomenon that has been poorly described in the literature.

METHODS

Case presentation.

RESULTS

The authors present a case of spontaneous resolution of vitreomacular traction following intravitreal administration of ranibizumab.

CONCLUSIONS

In patients with vitreomacular traction syndrome and diabetic macular edema, the combination of the possible vitreous liquefaction and mechanical increase of vitreous volume caused by an intravitreal injection with a degree of reduction in retinal thickness caused by the effect of vascular endothelial growth factor inhibition could play a role in the resolution of vitreomacular traction.